Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
12 NEW March 20, 2023
A molecular twist on bacterial cell shape

A molecular twist on bacterial cell shape

Dissecting the role of the cytoskeletal protein CcmA in the helical shape of Helicobacter pylori
Science Spotlight - October 17, 2022
How Helicobacter stays helical

How Helicobacter stays helical

New insights into how the cancer-causing stomach bacterium keeps its shape could point the way for future, more-specialized antibiotics
Hutch News - January 21, 2020
'You create your path': Panel of 'Rock Star Women in Science' inspire crowd

'You create your path': Panel of 'Rock Star Women in Science' inspire crowd

Top scientists from five research organizations spoke to sold out crowd about passion, science, confidence and pear farming
Hutch News - June 23, 2016
Three-drug H. pylori therapy better for some than four

Three-drug H. pylori therapy better for some than four

New results from large Latin American SWOG study contradict clinical trial findings in Europe and Asia; geographic variations in antibiotic resistance may validate different drug regimens for different populations
Hutch News - August 01, 2011
Salama, colleagues unlock ulcer bug’s structure

Salama, colleagues unlock ulcer bug’s structure

H. pylori’s corkscrew twist allows colonization; findings may lead to better drugs
Hutch News - June 01, 2010
Shape matters: the corkscrew twist of the ulcer bug H. pylori enables it to 'set up shop' in the stomach

Shape matters: the corkscrew twist of the ulcer bug H. pylori enables it to 'set up shop' in the stomach

Unlocking the keys to H. pylori's helical structure may lead to better antibiotic drugs for diseases from ulcers and stomach cancer to diarrhea and cholera
News Releases - May 27, 2010
Smith antibiotics study wins Gates grant

Smith antibiotics study wins Gates grant

The $100,000 one-year grant will fund the development of a new class of antimicrobial drugs to treat TB and limit the evolution of resistance to antibiotics
Hutch News - May 11, 2009